LeapZipBlog: robert henric

robert henric's blog

13 blogs

Global Endoscope Reprocessing Market Size, Status, Overview and Future Forecast

June 19, 2019 by robert henric  

According to the new market research report Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) — Global Forecast, published by MarketsandMarkets™, the global Endoscope Reprocessing Market is expected to reach USD 2.15 Billion, at a CAGR of 8.6%

Factors such as high risk of infections associated with improper sterilization of endoscopes, increasing investments, funds, and grants by government bodies across the globe, rising number of hospitals and growing hospital investments in endoscopy instruments, and rising prevalence of diseases that require endoscopy procedures are driving the growth of the Endoscope Reprocessing Market during the forecast period.

Download PDF Brochure:'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219094994" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219094994">https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219094994

 

Automated Endoscope Reprocessors (AERs) to account for the largest share of the Endoscope Reprocessing Market in 2017

On the basis of products, the market is segmented into high-level disinfectants and test strips; detergents and wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). The high-level disinfectants and test strips segment is expected to account for the largest share of the global Endoscope Reprocessing Market in 2017. The large share of this segment is attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/endoscope-reprocessing-market-219094994.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/endoscope-reprocessing-market-219094994.html">Endoscope Reprocessing Market

264 — Tables

52 — Figures

301 — Pages

Hospitals segment expected to account for the largest share of the market in 2017

On the basis of the end user, the Endoscope Reprocessing Market has been segmented into hospitals, ambulatory surgery centers, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2017, the hospital's segment is expected to account for the largest share of the global Endoscope Reprocessing Market. The ambulatory surgery centers (ASCs) segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. The high growth in this segment can be attributed to the increase in the number of endoscopic procedures performed in ASCs, and the rising preference of ASCs over hospitals.

North America dominated the market in 2017

North America accounted for the largest share of the Endoscope Reprocessing Market in 2017, followed by Europe. In the US, the Endoscope Reprocessing Market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections. In Canada, the growth of the Endoscope Reprocessing Market is driven by the availability of physician bonuses and the implementation of a new funding model for Canadian hospitals.

Read a Press-Release on “Endoscope Reprocessing Market”:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/endoscope-reprocessing.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/endoscope-reprocessing.asp">https://www.marketsandmarkets.com/PressReleases/endoscope-reprocessing.asp

The various players in the Endoscope Reprocessing Market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others

Global Ureteroscopy Market Size, and Growth Projection

June 19, 2019 by robert henric  

According to the new market research report Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) — Global Forecast to 2023”, published by MarketsandMarkets™, The Ureteroscopy Market is expected to reach USD 1,054.1 million by 2023 from USD 809.6 million in 2018, at a CAGR of 5.4%.

Factors such as the growing incidence of urolithiasis and technological advancements such as single-use ureteroscopes in flexible ureteroscopy are driving the growth of this market.

Download PDF Brochure “ Flexible & Semi-rigid Ureteroscopy Market”:'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795">https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795

 

Flexible ureteroscopes are expected to account for the largest share of the market in 2018

By type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share in 2018. The growing incidence of urolithiasis, rising prevalence rate of kidney cancers, and technological advancements in flexible ureteroscopes are the primary factors driving the growth of the Ureteroscopy Market. The flexible ureteroscopes market is further segmented into fiberoptic and digital ureteroscopes. The digital ureteroscopes segment is expected to account for the larger market share in 2018 owing to the higher efficacy and better image output of these devices.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/flexible-semi-rigid-ureteroscopy-market-253934795.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/flexible-semi-rigid-ureteroscopy-market-253934795.html">Ureteroscopy Market

157 — Tables

76 — Figures

212 — Pages

Urolithiasis applications to account for the largest share of the market in 2018

By application, this market is classified into urolithiasis, urinary stricture, and kidney cancer. Urolithiasis is the largest application segment in the market owing to the increasing prevalence of urolithiasis globally.

Hospitals are expected to dominate the flexible & semi-rigid ureteroscopy end-user market in 2018

By end user, the Ureteroscopy Market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment is expected to account for the largest share of the Ureteroscopy Market. This large share can be attributed to the high number of surgeries performed in hospitals.

North America to command the largest share of the Ureteroscopy Market in 2018

By region, the Ureteroscopy Market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region. Asia is expected to grow at the highest CAGR in the Ureteroscopy Market during the forecast period. Growth in this region is mainly due to the large patient population.

Read a Press Release on “Flexible & Semi-rigid Ureteroscopy Market”

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/flexible-semi-rigid-ureteroscopy.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/flexible-semi-rigid-ureteroscopy.asp">https://www.marketsandmarkets.com/PressReleases/flexible-semi-rigid-ureteroscopy.asp

Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).

Rat Model Market: Worldwide Industry Analysis and New Opportunities Explored

June 18, 2019 by robert henric  

According to the new market research report Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

The Global Rat Model Market is expected to reach $588.9 Million, growing at a CAGR of 8.7%

The global rat model market is segmented on the basis of model type, service, therapeutic area, technology, end user, care product, and region.

Read More in Detailed:'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/rat-model.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/rat-model.asp">https://www.marketsandmarkets.com/PressReleases/rat-model.asp

 

On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global rat model market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment owing to the use of this type of rat models to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/rat-model-market-76036494.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/rat-model-market-76036494.html">Rat Model Market

132 — Tables

47 — Figures

253 — Pages

On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN). In 2016, the CRISPR segment is expected to command the largest share of the global rat model market.

On the basis of therapeutic area, the market is segmented into toxicology, oncology, immunology & inflammation, diabetes, neurology, and other therapeutic areas (rare diseases, cardiovascular diseases, metabolic diseases, hematopoiesis, and renal disorders). In 2016, the toxicology segment is expected to command the largest share of the global rat model market.

On the basis of service, the market is segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model-in-licensing, and other services (surgical services, line rescue services, and in vivo pharmacology services). In 2016, the breeding services segment is expected to command the largest share of the global rat model market.

On the basis of end user, the rat model market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is expected to command the largest share of the global rat model market.

On the basis of care product, the market is segmented into bedding, cages, feed, and other products (gnotobiotic equipment, water systems, water purification systems, and sound absorption panels). In 2016, the cages segment is expected to command the largest share of the market.

Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the rat model market worldwide.

Know more about key industry players:'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/rat-model-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/rat-model-market.asp">https://www.marketsandmarkets.com/ResearchInsight/rat-model-market.asp

Rising Opportunities in the Emerging Industry to Boost the Growth of the Depth Filtration Market

June 18, 2019 by robert henric  

According to a new market research report Depth Filtration Market by Media Type (Diatomaceous Earth, Activated Carbon, Cellulose), Product (Filter Cartridge, Capsule Filter), Application (Final Product Processing (Small Molecules, Biologics), Cell clarification) — Global Forecast”, published by MarketsandMarkets™, the Global Depth Filtration Market is poised to reach $2.96 Billion, at a CAGR of 11.7%

The report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

Read a Press Release on “Depth Filtration Market

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/depth-filtration.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/depth-filtration.asp">https://www.marketsandmarkets.com/PressReleases/depth-filtration.asp

 

The growth in this market will majorly be driven by the increasing production of biologics and large molecules, as depth filtration plays a significant role in providing pure and quality products. Depth filters offer advantages such as low cost and ease of use; these advantages are driving their uptake in the market. However, low capacity of depth filters for high-density harvest is a key challenge in this market.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/depth-filtration-market-143876285.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/depth-filtration-market-143876285.html">Depth Filtration Market

71 — Tables

29 — Figures

127 — Pages

The Global Depth Filtration Market is broadly segmented on the basis of media type, product, application, and region. On the basis of media type, the Depth Filtration Market is segmented into diatomaceous earth, activated carbon, cellulose, and perlite. The diatomaceous earth filters segment is expected to account for the largest share of the Depth Filtration Market followed by activated carbon. This high share is attributed to its high-quality filtration and wide range of applications in the pharmaceutical and biopharmaceutical industry.

Furthermore, based on application, the Depth Filtration Market is categorized into final product processing, cell clarification, raw material filtration, and other applications. The final product processing segment is expected to account the largest share of the global Depth Filtration Market. The final product processing segmented is further divided into small molecule processing and biologics processing. The large share of the final product processing segment is attributed to the rapid growth in the biopharmaceutical industry, expansion in generics production, and the need for high-quality final products.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global Depth Filtration Market in 2017, followed by Europe. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR in the forecast period. Significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence are the major factors fueling the growth of the Depth Filtration Market in the Asia-Pacific region.

The Depth Filtration Market is dominated by established players such as Merck KGaA (Germany), Sartorius Stedim Biotech S.A. (France), and Pall Corporation (U.S.).

Know more about key industry players:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/depth-filtration-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/depth-filtration-market.asp">https://www.marketsandmarkets.com/ResearchInsight/depth-filtration-market.asp

Global Gynecology Surgical Instrument Market 2019: Industry Growth, Size, and Development

June 17, 2019 by robert henric  

According to the new market research report Gynecology Surgical Instrument Market by Product (Scissors, Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & End User (Hospital, Clinic, Ambulatory Surgery Center) — Global Forecast, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and Rest of the World (RoW)

The Global Gynecology Surgical Instrument Market is expected to reach USD 2.44 Billion, at a CAGR of 7.1% during the forecast period.

Read a Press-Release on “Gynecology Surgical Instrument Market”:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/gynecology-surgical-instrument.asp" rel="noopener nofollow" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/gynecology-surgical-instrument.asp">https://www.marketsandmarkets.com/PressReleases/gynecology-surgical-instrument.asp

 

The growth of the market is mainly driven by factors such as the high incidence of gynecological diseases, increasing awareness programs, and rising government investments for providing advanced healthcare facilities & services. However, increasing preference for robotic surgeries is the major factor that may restrain the growth of this market to a certain extent during the forecast period.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/gynecology-surgical-instrument-market-122824797.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/gynecology-surgical-instrument-market-122824797.html">Gynecology Surgical Instrument Market

157 — Tables

76 — Figures

212 — Pages

The report segments the Gynecology Surgical Instrument Market based on products, applications, end user, and region. On the basis of products, the market is segmented into forceps, scissors, needle holders, dilators, trocars, vaginal speculums, and other instruments. Forceps are expected to account for the largest share of the market, the growth of the forceps segment is attributed to the increase in the number of gynecological surgeries and the repeated use of forceps in most gynecological surgeries.

Based on application, the market is further segmented into laparoscopy, hysteroscopy, dilation and curettage, colposcopy, and other applications. Laparoscopy segment is expected to grow at the highest CAGR during the forecast period. Laparoscopy forms the largest and fastest-growing application segment of the market. This is mainly attributed to the various advantages of laparoscopy procedures, which includes less blood loss, shorter hospital stays, and fewer intraoperative & postoperative complications.

On the basis of end user, the market is categorized into hospitals, clinics, and ambulatory surgery centers. hospitals and clinics were expected to be the major end-user segment in the market. The large share of this segment can be attributed to the increasing incidence of gynecological diseases and the need for timely diagnosis and treatment of these diseases, growing government involvement in increasing awareness regarding women’s health issues, and increase in funding and infrastructural development in hospitals.

Based on region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of this market in 2016. However, the Asian market is expected to grow at the highest CAGR mainly due to the increasing awareness programs, high incidence of gynecological diseases, increasing government initiatives focusing on women’s health, and improvements in the healthcare sector of Asian countries.

The Gynecology Surgical Instrument Market is highly fragmented with several big and emerging players. Key market players include B. Braun Melsungen AG (Germany), CooperSurgical Inc. (U.S.), Ethicon, Inc. (U.S.), KARL STORZ GmbH & Co. KG (Germany), KLS Martin Group (U.S.), MedGyn Products (U.S.), Olympus Corporation (Japan), Richard WOLF GmbH (Germany), Sklar Surgical Instruments (U.S.), and Tetra Surgical (Pakistan).

Know more about key industry players-'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/gynecology-surgical-instrument-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/gynecology-surgical-instrument-market.asp">https://www.marketsandmarkets.com/ResearchInsight/gynecology-surgical-instrument-market.asp

Regenerative Medicine Market size, Demand, Analysis and Opportunity Forecast 2024

June 17, 2019 by robert henric  

According to the new market research report Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region — Global Forecast to 2024, published by MarketsandMarkets™, the Regenerative Medicine Market is expected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%.

Growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by FDA, increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds among others.

Read a Press Release on “Regenerative Medicine Market”:'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/regenerative-medicine.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/regenerative-medicine.asp">https://www.marketsandmarkets.com/PressReleases/regenerative-medicine.asp

 

Cell-based immunotherapy & cell therapy products segment dominated the Regenerative Medicine Market in 2019.

On the basis of type, the Regenerative Medicine Market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products. The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, the establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html">Regenerative Medicine Market

76 — Tables

29 — Figures

107 — Pages

Musculoskeletal disorders applications segment likely to dominate the market in 2019.

On the basis of application, the Regenerative Medicine Market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. In 2019, the musculoskeletal disorders segment accounted for the largest market share. The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with a rising geriatric population.

North America anticipated accounting for the largest share of the Regenerative Medicine Market in 2019.

The Regenerative Medicine Market in North America is expected to account for the largest share globally and also grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine, the introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.

The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this Regenerative Medicine Market.

Know more about key industry players:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/regenerative-medicine-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/regenerative-medicine-market.asp">https://www.marketsandmarkets.com/ResearchInsight/regenerative-medicine-market.asp

Global Single cell Analysis Market 2019: Opportunities, Challenges, and Forecast

June 14, 2019 by robert henric  

According to the new market research report Single cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User — Global Forecast, published by MarketsandMarkets™, The single cell analysis market is expected to reach $ 3.59 Billion, at a CAGR of 16.5%

The growth in this market is mainly driven by the technological advancements in single cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.

Read a Press Release on “Single cell Analysis Market”

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/single-cell-analysis.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/single-cell-analysis.asp">https://www.marketsandmarkets.com/PressReleases/single cell-analysis.asp

 

Consumables estimated to dominate the market in 2017

Based on the type of products, the single cell analysis market is segmented into consumables and instruments. The consumables segment is expected to dominate this market, primarily due to the requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html">Single cell Analysis Market

107 — Tables

42 — Figures

175 — Pages

Flow cytometry to have the largest market share in 2017

On the basis of technique, the single cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). In 2017, flow cytometry is expected to dominate the market. Wide usage of flow cytometry in single cell analysis applications is expected to boost the demand for single cell analysis techniques.

North America to dominate the market followed by Europe

On the basis of the region, the single cell analysis market is segmented into North America, Europe, Asia, and RoW. In 2017, North America accounted for the largest share of the market, followed by Europe. The large share of the North American market is attributed to the factors such as increasing collaborations among prominent players, technological advancements, and expanding biotechnology and pharmaceutical industries. Factors such as increasing incidence of diseases, government support for various research activities, and growing focus on stem cell research and regenerative medicine are expected to fuel the market growth in the European region.

The single cell analysis market is highly competitive with the presence of major players. Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.)

Know more about key industry players:'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/single-cell-analysis-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/single-cell-analysis-market.asp">https://www.marketsandmarkets.com/ResearchInsight/single cell-analysis-market.asp

Research Insights on Veterinary Chemistry Analyzer Market Share, Size and Analysis Report

June 14, 2019 by robert henric  

According to the new market research report Veterinary Chemistry Analyzer Market by Product (Chemistry Analyzer, Glucometer, Consumables (Panel, Test Strip, Reagent)) Application (Blood Chemistry Analysis, Urinalysis, Glucose Monitoring) & Animal (Companion & Livestock) — Global Forecast”,published by MarketsandMarkets™, the Global Veterinary Chemistry Analyzer Market is estimated to grow at a CAGR of 8.7%, to reach USD 1,205.2 Million.

The growth in this market is majorly attributed to factors such as growing livestock and companion animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, raising awareness about zoonotic diseases, and an increasing number of veterinary practitioners across the globe.

Read a Press Release on “Veterinary Chemistry Analyzer Market”:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/veterinary-chemistry-analyzer.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/veterinary-chemistry-analyzer.asp">https://www.marketsandmarkets.com/PressReleases/veterinary-chemistry-analyzer.asp

 

The Global Veterinary Chemistry Analyzer Market is segmented on the basis of product, application, animal type, and region. On the basis of product, this market is segmented into instruments and consumables (panels, kits, test strips, and reagents). In 2016, the consumables segment accounted for the largest share of the global Veterinary Chemistry Analyzer Market. It is expected to register the highest growth during the forecast period. The high growth of this segment is mainly attributed to the increased adoption of the pre-loaded multiple reagent panels and pre-loaded single slide reagent panels by the end users.

Browse and in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/veterinary-chemistry-analyzer-market-48798056.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/veterinary-chemistry-analyzer-market-48798056.html">Veterinary Chemistry Analyzer Market

206 — Tables

24 — Figures

250 — Pages

On the basis of application, the market is categorized into blood chemistry analysis, urinalysis, glucose monitoring, and blood gas-electrolyte analysis. The blood chemistry analysis segment accounted for the largest share, while the glucose-monitoring segment is expected to witness the highest growth during the forecast period. The Veterinary Chemistry Analyzer Market is further segmented, on the basis of animal type, into companion animals and livestock. The companion animal segment accounted for the largest share of the market. This segment is also expected to register the highest growth during the forecast period.

The report also provides a detailed geographic analysis of the Veterinary Chemistry Analyzer Market covering developed and emerging economies. The developed market includes the U.S., Canada, Germany, the U.K., France, Italy, Spain, and Japan while the emerging market includes China, India, and Latin America. The U.S. attributed the largest share of the developed market owing to its well-established animal healthcare systems. The large share of this regional market segment is driven by increasing demand for animal-derived food products, rising animal healthcare expenditure, growing animal population, and raising awareness about zoonotic diseases.

Some of the prominent players in this market are IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), Heska Corporation (U.S.), Randox Laboratories Ltd. (U.K.), ARKRAY, Inc. (Japan), Eurolyser Diagnostica GmbH (Austria), Alfa Wassermann Inc. (U.S.), DiaSys Diagnostic Systems, USA, LLC (U.S.), Diconex SA (Argentina), Chengdu Seamaty Technology Co., Ltd.(China), Biochemical Systems International Srl (Italy), ELITechGroup (France), and URIT Medical Electronic Group Co. Ltd (China).

Know more about key industry players:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/veterinary-chemistry-analyzer-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/veterinary-chemistry-analyzer-market.asp">https://www.marketsandmarkets.com/ResearchInsight/veterinary-chemistry-analyzer-market.asp

Global Central Fill Pharmacy Automation Market 2019 Key highlights, Segmentation, Overview and Forecast

June 14, 2019 by robert henric  

According to the new market research report Central Fill Pharmacy Automation Market by Product (Equipment (Medication Dispensing System, Automated Medication Compounding Systems, Workflow Management), Service (Process Optimization, Facility Design), Software), Vendor — Global Forecast to 2024”, published by MarketsandMarkets™, the Central Fill Pharmacy Automation Market is projected to reach USD 656 million by 2024 from USD 381 million in 2019, at a CAGR of 11.5%.

Read a Press Release on “Central Fill Pharmacy Automation Market”

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/PressReleases/central-fill-pharmacy-automation.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/PressReleases/central-fill-pharmacy-automation.asp">https://www.marketsandmarkets.com/PressReleases/central-fill-pharmacy-automation.asp

 

The increasing demand for specialty drugs being dispensed by central fill pharmacies is one of the primary drivers propelling the growth of this market. Other factors such as the need to minimize medication errors, growing patient volume (which in turn is increasing the burden on pharmacies), and the growing focus on automation to reduce labor costs are also driving market growth.

By-product and service, the equipment segment is expected to account for the largest share of the Central Fill Pharmacy Automation Market

The Central Fill Pharmacy Automation Market, by product and service, is segmented into equipment, services, and software. The equipment segment accounted for the largest market share in 2018. A number of automated systems are used in facilities offering the advantages of freeing up manpower, allowing greater throughput, and increasing the number of processed prescriptions. These facilities form an indispensable tool for central fill pharmacies to improve the prescription assembly, verification, and delivery back to the pharmacy. This contributes to the large share of the segment.

Browse in-depth TOC on “'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/Market-Reports/central-fill-pharmacy-automation-market-87188549.html" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/Market-Reports/central-fill-pharmacy-automation-market-87188549.html">Central Fill Pharmacy Automation Market

60 — Tables

23 — Figures

126 — Pages

The equipment vendors are increasing with the increasing demand for automation systems

Based on vendor, the Central Fill Pharmacy Automation Market is segmented into equipment vendors and consulting vendors. The equipment vendors segment is estimated to account for the largest market share in 2018. This is mainly attributed to their broad product portfolio, vast geographic presence, strong technical expertise, and easy access to spare parts (resulting in reduced downtime).

North America is expected to dominate the Central Fill Pharmacy Automation Market during the forecast period

In 2018, North America dominated the Central Fill Pharmacy Automation Market, followed by Europe, and this trend is expected to continue during the forecast period. The rising focus on providing value-based care to patients, increase in specialty medication dispensing, growing number of medication errors, and the need for automated systems for improved compounding and dispensing are major factors that have resulted in the increased adoption of central fill pharmacy automation equipment and services in North America.

Prominent players in the Central Fill Pharmacy Automation Market are ARxIUM, Inc. (US), RxSafe, LLC (US), TCGRX Pharmacy Workflow Solutions (US), McKesson Corporation (US), Omnicell, Inc. (US), ScriptPro (US), Kuka AG (Germany), Innovation (US), R/X Automation Solutions (US), Tension Packaging & Automation (US), Cornerstone Automation Systems, LLC (CASI, US), and QMSI (US)

Know more about key industry players:

'); background-size: 1px 1px; background-position: 0px calc(1em + 1px);" href="https://www.marketsandmarkets.com/ResearchInsight/central-fill-pharmacy-automation-market.asp" rel="nofollow noopener" target="_blank" data-href="https://www.marketsandmarkets.com/ResearchInsight/central-fill-pharmacy-automation-market.asp">https://www.marketsandmarkets.com/ResearchInsight/central-fill-pharmacy-automation-market.asp

Rat Model Market: Worldwide Industry Analysis and New Opportunities Explored

June 12, 2019 by robert henric  

The Global Rat Model Market is expected to reach the US $ 588.9 million, growing at a CAGR of 8.7%

Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market. The rat model market is expanding with the increase in R&D activities in pharmaceutical industries.

Rat Model Market

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76036494

The development of advanced rat genome manipulation techniques (such as the creation of transgenic rats and knockout rats), drives the global rat model market.

Preclinical animal models, such as mice and rats that are used to predict drug efficacy and toxicity in humans, are needed. Rats are commonly used due to their genetic similarity to humans as well as their unlimited supply and ease of manipulation. Knockout rats are produced by inactivating/silencing or “knocking out” an existing gene and replacing it with an artificial piece of DNA, thereby resulting in the loss of gene activity.

Rat Model Market segmentation:

· based on the model type

· based on service

· based on therapeutic area

· based on technology

· based on care product

· based on end users

Geographical Detailed Analysis for Rat Model Market:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

TOXICOLOGY-

Toxicology is the study of adverse effects of chemical, physical, or biological agents on people, animals, and the environment. Rats are predominantly used in the toxicity and safety assessment studies of a drug substance. Other animals that are used in these studies include mice, rabbits, and guinea pigs. Toxicology testing in animals is required to prove that the new drugs are safe before their administration in humans. A high proportion of new drugs fail in the preclinical stage is due to the unacceptable toxicity in animals.

ONCOLOGY-

Rat models recapitulate various aspects of genesis, progression, and clinical course of human cancers. Hence, they act as ideal study models for cancer researchers engaged in a variety of basic, translational, clinical, and epidemiological investigations.

Read Press-Release on Rat Model Market

https://www.marketsandmarkets.com/PressReleases/rat-model.asp

The Major Players Operating in the Rat Model Market:

Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the rat model market worldwide.

Charles River Laboratories International, Inc., dominated the global rat model and services market with a share of around 42.0%. The company has aggressively adopted the acquisition strategy. It acquired seven companies in the last four years to improve its production and distribution capabilities as well as to strengthen its products and service portfolio.